Multicorp Intl Inc.
MultiCorp International, Inc. engages in medical business in the United States. It offers health care and technology services. The company was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. The company was incorporated in 2002 and is based in Agoura Hills, California.
Multicorp Intl Inc. (MCIC) - Net Assets
Latest net assets as of March 2025: $4.79 Million USD
Based on the latest financial reports, Multicorp Intl Inc. (MCIC) has net assets worth $4.79 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.20 Million) and total liabilities ($409.21K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.79 Million |
| % of Total Assets | 92.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | -147.88% |
| 10-Year Change | N/A |
| Growth Volatility | 117.09 |
Multicorp Intl Inc. - Net Assets Trend (2008–2024)
This chart illustrates how Multicorp Intl Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Multicorp Intl Inc. (2008–2024)
The table below shows the annual net assets of Multicorp Intl Inc. from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-207.30K | -20.63% |
| 2023-12-31 | $-171.84K | -43.96% |
| 2022-12-31 | $-119.37K | -97.71% |
| 2021-12-31 | $-60.37K | -113.94% |
| 2014-12-31 | $432.96K | +1741.82% |
| 2013-12-31 | $-26.37K | -106.59% |
| 2011-12-31 | $399.98K | -3.75% |
| 2010-12-31 | $415.55K | +176.24% |
| 2009-12-31 | $150.43K | +129.34% |
| 2008-12-31 | $-512.66K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Multicorp Intl Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 25073800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $131.23 | % |
| Other Components | $219.48K | % |
| Total Equity | $-207.30K | 100.00% |
Multicorp Intl Inc. Competitors by Market Cap
The table below lists competitors of Multicorp Intl Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
General Accident PLC
LSE:GACA
|
$126.54 |
|
Classover Holdings, Inc. Warrants
NASDAQ:KIDZW
|
$127.05 |
|
Blue Star Opportunities Corp
PINK:BSTO
|
$127.34 |
|
Portmeirion Group
LSE:PMGR
|
$127.39 |
|
Crystal Amber Fund Limited
LSE:CRS
|
$126.07 |
|
Powerstone Metals Corp.
PINK:PWMCF
|
$126.04 |
|
PICIC Insurance Ltd
KAR:PIL
|
$125.98 |
|
Electric Guitar PLC
LSE:ELEG
|
$125.95 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Multicorp Intl Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -171,844 to -207,303, a change of -35,459.
- Net loss of 35,458 reduced equity.
- Other comprehensive income increased equity by 131.
- Other factors decreased equity by 132.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-35.46K | -17.1% |
| Other Comprehensive Income | $131.00 | +0.06% |
| Other Changes | $-132.00 | -0.06% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Multicorp Intl Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.00 | $0.01 | x |
| 2019-12-31 | $0.00 | $0.01 | x |
| 2020-12-31 | $0.00 | $0.01 | x |
| 2021-12-31 | $0.00 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
| 2024-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Multicorp Intl Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-6056.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | -215.68% | 0.82x | 0.00x | $-79.51K |
| 2009 | -221.55% | -2822.53% | 0.03x | 3.02x | $-348.33K |
| 2010 | -92.76% | 0.00% | 0.00x | 1.71x | $-427.00K |
| 2011 | -3.89% | 0.00% | 0.00x | 1.74x | $-55.57K |
| 2013 | 0.00% | 47.69% | 63.97x | 0.00x | $614.73K |
| 2014 | 105.86% | 71.39% | 1.45x | 1.02x | $415.04K |
| 2019 | -72463.77% | 0.00% | 0.00x | 1.00x | $-400.06K |
| 2020 | -0.10% | 0.00% | 0.00x | 1.00x | $-31.02K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-54.59K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-47.06K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-35.29K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.73K |
Industry Comparison
This section compares Multicorp Intl Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Multicorp Intl Inc. (MCIC) | $4.79 Million | 0.00% | 0.09x | $126.21 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |